Doximity: 3 Key Takeaways for Long-Term Investors

On its fiscal 2027 second-quarter earnings call, held on Nov. 5, 2026, Doximity (DOCS +1.11%) reported revenue of $175 million as artificial intelligence adoption expanded across its platform. Clinicians rely on Doximity’s digital tools for daily medical workflows, creating a captive professional audience that attracts pharmaceutical advertising spend. Efficient compute management keeps profit margins intact as AI usage scales. Three things management said stand out.

1. Commercial AI Search Opens Access to Paid Search Budgets

Pharma clients are adopting Doximity’s new AI search capabilities to engage physicians at the point of care. Entering keyword-driven search opens up a $14 billion annual market for digital pharma budgets.

Last, on the pharma side, our AI search commercial offering has been well received. 16 of the Top 20 pharma companies have already purchased with 3 more in contracting.
— Jeffrey A. Tangney, Cofounder and Chief Executive Officer

2. Workflow Active Users Surpass Half of All U.S. Prescribers

Broad physician engagement forms the foundation of Doximity’s platform value. As more doctors use digital scheduling, telehealth, and AI clinical tools, the network doesn’t have to spend a fortune hunting for new users.

Quarterly active workflow prescribers, which includes our AI users, grew 34% year-on-year to record highs, accelerating from last quarter.
— Jeffrey A. Tangney, Cofounder and Chief Executive Officer

3. Compute Infrastructure Gains Drive AI Cost Leverage

Running complex AI models can erode software margins if inference costs spiral out of control. Management prebought compute capacity and optimized its technical infrastructure, keeping revenue cost growth well behind prompt volume growth.

Even with significant engagement increases, we realized AI cost leverage. Efficiency drivers include prebuying more capacity at favorable economics, greater multimodal usage, and continued performance gains in our proprietary harness.
— Matthew Sonefeldt, Chief Financial Officer

Looking Ahead

Clinical workflow tools are becoming essential infrastructure across hospital networks. Electronic health record (EHR) software that manages medical notes, integration, and medical reference partnerships fortifies Doximity’s competitive moats while cementing physician reliance on the platform.

With dose check and UpToDate, we lead on AI accuracy and trust. With 190 health system AI clients and patient context, we lead on distribution and integration.
— Jeffrey A. Tangney, Cofounder and Chief Executive Officer

Updated full-year revenue guidance of $678 million to $683 million signals steady demand and pricing discipline. Operating efficiency protects cash generation as Doximity expands deeper into digital search budgets.

Improving efficiency in our AI investments allows us to continue playing offense in the midst of this generational technology shift.
— Matthew Sonefeldt, Chief Financial Officer

The Motley Fool has positions in and recommends Doximity. The Motley Fool has a disclosure policy.

Source: www.fool.com — article syndicated from the publisher’s feed; all rights remain with the original publisher.